These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17545641)

  • 21. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed exercise-induced protection against arrhythmias in dogs--effect of celecoxib.
    Nagy O; Hajnal A; Parratt JR; Végh A
    Eur J Pharmacol; 2004 Sep; 499(1-2):197-9. PubMed ID: 15363967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2-derived endogenous prostacyclin reduces apoptosis and enhances embryo viability in mouse.
    Pakrasi PL; Jain AK
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):27-33. PubMed ID: 18771909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
    Zhao S; Cai J; Bian H; Gui L; Zhao F
    Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New celecoxib derivatives as anti-inflammatory agents.
    Szabó G; Fischer J; Kis-Varga A; Gyires K
    J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
    Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.
    Rudner J; Elsaesser SJ; Müller AC; Belka C; Jendrossek V
    Biochem Pharmacol; 2010 Jan; 79(1):10-20. PubMed ID: 19665451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.
    Maussang D; Langemeijer E; Fitzsimons CP; Stigter-van Walsum M; Dijkman R; Borg MK; Slinger E; Schreiber A; Michel D; Tensen CP; van Dongen GA; Leurs R; Smit MJ
    Cancer Res; 2009 Apr; 69(7):2861-9. PubMed ID: 19318580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib inhibits serum amyloid a-induced matrix metalloproteinase-10 expression in human endothelial cells.
    Zhao Y; Zhou S; Heng CK
    J Vasc Res; 2009; 46(1):64-72. PubMed ID: 18552508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer.
    Zhou Y; Ran J; Tang C; Wu J; Honghua L; Xingwen L; Ning C; Qiao L
    Cancer Biol Ther; 2007 Feb; 6(2):269-75. PubMed ID: 17224647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
    Kapoor S; Bahde R
    Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents.
    Mehar A; Macanas-Pirard P; Mizokami A; Takahashi Y; Kass GE; Coley HM
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1181-7. PubMed ID: 18089846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
    Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
    Wang CH; Zheng WB; Qiang O; Tang CW
    J Dig Dis; 2009 May; 10(2):91-8. PubMed ID: 19426390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S; Tong Q; Zhang W; Wang Q; Chen Z; Wu Q
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.